{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:04:28Z","timestamp":1788458668300,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"GAVI the Global Alliance for Vaccines and Immunization, and the Vaccine Fund"},{"DOI":"10.13039\/501100000226","name":"MOHLTC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.vaccine.2011.09.024","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T17:15:11Z","timestamp":1316538911000},"page":"8580-8584","source":"Crossref","is-referenced-by-count":67,"title":["Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program"],"prefix":"10.1016","volume":"29","author":[{"given":"Peter","family":"Tanuseputro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Zagorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.vaccine.2011.09.024_bib0005","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.09.024_bib0010","series-title":"Press Release: Zostavax\u2122. Report","author":"Merck Frosst","year":"2009"},{"issue":"5","key":"10.1016\/j.vaccine.2011.09.024_bib0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"issue":"37","key":"10.1016\/j.vaccine.2011.09.024_bib0020","first-page":"884","article-title":"Decline in annual incidence of varicella \u2013 selected states, 1990\u20132001","volume":"52","author":"Centers for Disease Control and Prevention (CDC)","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2011.09.024_bib0025","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.024_bib0030","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1542\/peds.2004-0012","article-title":"Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States","volume":"114","author":"Davis","year":"2004","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.vaccine.2011.09.024_bib0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.294.7.797","article-title":"Impact of varicella vaccination on health care utilization","volume":"294","author":"Zhou","year":"2005","journal-title":"JAMA"},{"issue":"47","key":"10.1016\/j.vaccine.2011.09.024_bib0040","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1016\/j.vaccine.2008.08.016","article-title":"Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program?","volume":"26","author":"Kwong","year":"2008","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2011.09.024_bib0045","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0264-410X(01)00437-6","article-title":"The cost-effectiveness of varicella vaccination in Canada","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2011.09.024_bib0050","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.287.17.2211","article-title":"Varicella vaccine and shingles","volume":"287","author":"Brisson","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.024_bib0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/jinf.2002.0988","article-title":"The effect of vaccination on the epidemiology of varicella zoster virus","volume":"44","author":"Edmunds","year":"2002","journal-title":"J Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.09.024_bib0060","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1002\/jmv.10317","article-title":"Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV","volume":"70","author":"Brisson","year":"2003","journal-title":"J Med Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.09.024_bib0065","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992\u20132002","author":"Jumaan","year":"2005","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.024_bib0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S095026880400281X","article-title":"Incidence of herpes zoster, 1997\u20132002","volume":"133","author":"Mullooly","year":"2005","journal-title":"Epidemiol Infect"},{"issue":"Suppl2","key":"10.1016\/j.vaccine.2011.09.024_bib0075","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/522162","article-title":"The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review","volume":"197","author":"Reynolds","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.09.024_bib0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2458-5-68","article-title":"The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998\u20132003","volume":"5","author":"Yih","year":"2005","journal-title":"BMC Public Health"},{"issue":"13","key":"10.1016\/j.vaccine.2011.09.024_bib0085","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.vaccine.2010.01.036","article-title":"A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia","volume":"28","author":"Carville","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.024_bib0090","series-title":"Supply and Utilization of General Practitioner and Family Physician Services in Ontario. ICES Investigative Report","author":"Chan","year":"2005"},{"key":"10.1016\/j.vaccine.2011.09.024_bib0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-9-55","article-title":"Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998\u20132004)","volume":"9","author":"Gil","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2011.09.024_bib0100","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/591975","article-title":"Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States","volume":"29","author":"Patel","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.09.024_bib0105","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1017\/S0950268807007893","article-title":"Secular trends in the epidemiology of shingles in Alberta","volume":"135","author":"Russell","year":"2007","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.024_bib0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","article-title":"Epidemiology of varicella zoster virus infection in Canada and the United Kingdom","volume":"127","author":"Brisson","year":"2001","journal-title":"Epidemiol Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2011.09.024_bib0115","first-page":"1","article-title":"The burden of varicella and zoster in British Columbia 1994\u20132003: baseline assessment prior to universal vaccination","volume":"33","author":"Edgar","year":"2007","journal-title":"Can Commun Dis Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.024_bib0120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database","volume":"20","author":"Insinga","year":"2005","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.024_bib0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1370\/afm.707","article-title":"Clinical diagnosis of herpes zoster in family practice","volume":"5","author":"Opstelten","year":"2007","journal-title":"Ann Fam Med"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.024_bib0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D391R2G01N","article-title":"Why do so many clinicians believe that recurrent zoster is common?","volume":"13","author":"Chien","year":"2007","journal-title":"Dermatol Online J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T20:27:00Z","timestamp":1686342420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11014307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":26,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0264410X11014307"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}